Sign in

    David RisingerLeerink Partners

    David Risinger's questions to Eli Lilly and Co (LLY) leadership

    David Risinger's questions to Eli Lilly and Co (LLY) leadership • Q4 2024

    Question

    In a follow-up, David Risinger of Leerink Partners asked for clarification on a comment about additional PBM coverage coming in March.

    Answer

    Executive Jacob Van Naarden clarified that the comment referred to the newly launched Ebglyss, for which coverage from two of the three major PBMs is expected. He noted that Mounjaro already has full PBM coverage.

    Ask Fintool Equity Research AI